Ecphora Capital
Ecphora Capital is a Baltimore-based early-stage venture capital firm investing in medtech startups across medical devices, biotech, digital health, and healthtech, sourcing deal flow from Maryland research institutions and supporting founders through proprietary assessment and seminar programs.
- Company typePrivate
- Founded2022
- HeadquartersBaltimore, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Ecphora Capital does
Ecphora Capital is a Baltimore, Maryland-based venture capital firm founded in 2022 that invests in early-stage medtech startups. The firm operates a single investment platform with four explicit thesis areas — Medical Device, Biotech, Digital Health, and HealthTech — and supports portfolio companies through a proprietary three-month data-driven startup assessment program that evaluates product-market fit, technical feasibility, IP landscape, and exit feasibility, paired with a quarterly CEO seminar series addressing the 29 most common factors leading to startup failure.
The firm's core competitive mechanism is regional deal-flow sourcing. Ecphora holds core-tier partnerships with Johns Hopkins University and Hospital System, the University of Maryland system (Baltimore, Baltimore County, and College Park), NIH, NIST, The LaunchPort, J&J Innovation JLabs, and other Maryland-area accelerators, which it describes as providing exclusive or preferred first-look access to promising medtech companies. Its disclosed portfolio of 10 companies (Theradaptive, Longeviti, Coaptech, MiHelper, Sonogen, Pathotrak, ARMR Systems, CoolTech, JuneBrain, and NovelDx) plus NextStep Robotics represents $15M+ of capital deployed.
Commercially, Ecphora generates returns through equity ownership in portfolio companies exited via IPOs, acquisitions, or secondary sales, and supplements this with SPV (Special Purpose Vehicle) administrative services delivered through its partnership with SPV Concierge Services. The firm is founder-led by Managing Partner Deborah Hemingway, PhD (Biophysics), supported by Managing Director and Head of Operations Jeremy Neilson and Venture Partner Sathya Janardhanan. No fund size, AUM, revenue, or fund-close disclosures are available, and the firm remains private with 1–10 employees.
Ecphora Capital firmographics
Firmographics- Name
- Ecphora Capital
- Legal name
- Ecphora Capital
- Website
- https://ecphoracapital.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ecphora Capital is a Baltimore-based early-stage venture capital firm investing in medtech startups across medical devices, biotech, digital health, and healthtech, sourcing deal flow from Maryland research institutions and supporting founders through proprietary assessment and seminar programs.
- Ownership category
- akta.pro rank
Ecphora Capital industry classification
Industry- Product category
- Medtech Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
Keywords
Where Ecphora Capital is headquartered
LocationHeadquarters
- HQ city
- Baltimore
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ecphora Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture Capital Returns: Ecphora Capital generates returns through equity ownership in portfolio companies, exited via IPOs, acquisitions, or secondary sales. The firm deploys capital into early-stage medtech startups and provides ongoing support to maximize portfolio value.
- SPV (Special Purpose Vehicle) Services: Through their partnership with SPV Concierge Services, the firm offers sophisticated SPV services to guide ventures through the SPV lifecycle, serving organizations and syndicators with administrative and transaction support.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Ecphora Capital product offering
Product offeringCore offering
Ecphora Capital is a Baltimore-based venture capital firm that invests in and supports early-stage medtech startups across medical device, biotech, digital health, and healthtech sectors. The firm provides capital deployment, a proprietary three-month data-driven startup assessment program, a quarterly CEO seminar series addressing the 29 most common factors leading to startup failure, and SPV (Special Purpose Vehicle) administrative services for ventures and syndicators.
Product overview
Ecphora Capital is Maryland's premier medtech venture capital firm operating as a single unified investment platform with four core investment focus areas (Medical Device, Biotech, Digital Health, and HealthTech) supported by three proprietary services: the Ecphora Seminar Series (quarterly educational programming for portfolio CEOs), the Proprietary Startup Assessment Program (a three-month data-driven evaluation across product-market fit, technical feasibility, IP landscape, and exit feasibility), and SPV Concierge Services (administrative and operational support for special purpose vehicles). The firm leverages strategic partnerships with regional research institutions including Johns Hopkins, University of Maryland, NIH, and NIST to source deal flow, and has deployed over $15M into medical startups while being involved in the founding, funding, and board membership of 53 startups.
Differentiator
Problem solved
Functional benefit
Products and services
- Proprietary Startup Assessment Program A data-driven, three-month evaluation program based on over 20 years of entrepreneurial research that thoroughly assesses startups on four critical success parameters: product-market fit, technical feasibility, IP landscape, and exit feasibility. Designed for early-stage medtech startups seeking investment and structured evaluation.
- Ecphora Seminar Series A quarterly seminar series where medtech startup CEOs benefit from a data-driven curriculum and robust support network, offering guidance, structure, mentorship, and camaraderie while tackling the 29 most common factors leading to startup failure.
- SPV Concierge Services A comprehensive SPV service offered through partnership with SPV Concierge Services that guides ventures through the lifecycle of the SPV, serving organizations and syndicators with a dedicated team of specialists focused on transactions, investors, and administrative requirements.
Companies that use Ecphora Capital
Customer profileNamed customers10 records
Segments1 record
Ideal customer profiles2 records
Ecphora Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ecphora Capital partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- The LaunchPort (Baltimore)coreMedical device manufacturing accelerator and venture center providing Ecphora Capital with exclusive first-look access to promising early-stage medtech companies.
- Johns Hopkins University and Hospital SystemcoreWorld-renowned medical research and academic institution in Baltimore providing access to cutting-edge biomedical innovations and talent pipeline for deal flow.
- University of Maryland, BaltimorecoreResearch and academic institution providing access to biomedical innovations and startup pipeline from the university ecosystem.
- University of Maryland, Baltimore CountyminorResearch and academic institution contributing to the startup ecosystem and providing potential deal flow for the firm.
- University of Maryland, College ParkminorResearch and academic institution providing access to innovations and startup pipeline through the xFoundry partnership.
- National Institutes of Health (NIH)coreGovernment scientific and medical research institution in Bethesda providing access to world-class research and potential spin-off companies.
- National Institutes of Standards and Technology (NIST)minorGovernment scientific and medical research institution in Gaithersburg providing access to standardization expertise and potential innovations.
- Maryland Tech CouncilminorTechnology trade organization and venture mentoring program providing ecosystem connections and startup support.
- NucleateminorGlobal biotech community and startup accelerator providing access to early-stage biotech companies worldwide.
- FITCI (Frederick)minorMedical startup incubator in Frederick providing access to early-stage companies and mentorship resources.
- J&J Innovation – JLabs (Washington DC)coreLife science and healthcare incubator in Washington DC providing access to promising startups and industry expertise from Johnson & Johnson's innovation network.
- xFoundry (College Park)minorAcademic-based startup studio and accelerator at University of Maryland College Park providing access to university-born startups.
- SPV Concierge ServicescoreComprehensive SPV service provider that guides ventures through the SPV lifecycle, serving Ecphora Capital with dedicated specialists for transactions, investors, and administrative requirements.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Ecphora Capital competitors and assessment
Company assessmentDirect peers
- Epidarex Capital: Early-stage life-sciences venture capital firm with strong academic-institution deal-flow orientation. Comparable as a thesis-driven, specialist life-sciences investor targeting university spinouts — similar stage and institutional-partnership model, albeit UK/US-headquartered.
- Pivotal bioVenture Partners: Early-stage life-sciences venture firm focused on seed and Series A therapeutics and platform investments. Comparable as a specialist, founder-led emerging manager targeting similar founders, check sizes, and medtech/biotech mandate.
- Hatteras Venture Partners: Early-stage venture firm investing in life sciences and healthcare across the U.S. Southeast/Mid-Atlantic. Comparable in stage focus (seed/Series A), sector specialization (biotech/medtech), and emerging-manager profile.
- BioHealth Innovation (BHI): Maryland-based regional innovation intermediary that commercializes BioHealth IP from research institutions across the state. Most directly comparable peer — operates in the same regional deal-flow ecosystem, with overlapping institutional partners (NIH, NIST, University of Maryland) and similar early-stage medtech commercialization mandate.
- Maryland Momentum Fund: University of Maryland-affiliated venture fund investing in companies leveraging UMD IP and talent — directly overlaps with Ecphora's University of Maryland partnership tier and BioHealth Capital Region thesis.
Broad incumbents
- New Enterprise Associates (NEA): Large multi-stage venture firm with a long-standing healthcare and life-sciences practice. Comparable as a scaled competitor for medtech deals and follow-on capital; relevant for benchmarking check sizes and exit paths for Ecphora's portfolio companies.
- Johnson & Johnson Innovation – JLABS: Corporate life-science incubator network that is itself a Core strategic partner of Ecphora. Comparable as an institutional medtech/healthcare investor and ecosystem builder — a much larger, well-capitalized player offering deal-flow overlap and partnership economics relevant to Ecphora's pipeline.
- Roche Venture Fund: Corporate venture arm of Roche investing broadly in early-stage biotech, diagnostics, and digital health. Comparable as a strategic corporate investor competing for the same medtech/biotech startup pool that Ecphora targets.
- OrbiMed Advisors: Large, healthcare-dedicated investment firm across private equity, venture, and royalty strategies. Comparable as a medtech specialist at vastly greater scale; provides the principal competitive benchmark for Ecphora's deal terms, ownership, and exit economics.
Regional players
- TEDCO (Maryland Technology Development Corporation): State-backed Maryland technology and life-science seed/venture investor. Comparable as a regional capital provider in the BioHealth Capital Region, though broader than medtech and earlier-stage, with public-policy mandate similar in spirit to Ecphora's 'Maryland commercialization' thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ecphora Capital social profiles
Digital presenceEcphora Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ecphora Capital leadership team
Management profileNumber of profiles
Profiles3 records
Ecphora Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ecphora Capital M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ecphora Capital
What does Ecphora Capital do?
Ecphora Capital is a Baltimore-based venture capital firm that invests in and supports early-stage medtech startups across medical device, biotech, digital health, and healthtech sectors. The firm provides capital deployment, a proprietary three-month data-driven startup assessment program, a quarterly CEO seminar series addressing the 29 most common factors leading to startup failure, and SPV (Special Purpose Vehicle) administrative services for ventures and syndicators.
Is Ecphora Capital a public or private company?
Ecphora Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ecphora Capital founded?
Ecphora Capital was founded in 2022. It employs 1 to 10 people.
Where is Ecphora Capital based?
Ecphora Capital is headquartered in Baltimore, United States, in the North America region.
How does Ecphora Capital make money?
Two revenue lines are on record. Venture Capital Returns are the primary driver. The others are SPV (Special Purpose Vehicle) Services.
Who are Ecphora Capital's main competitors?
Direct peers on record are Epidarex Capital, Pivotal bioVenture Partners, Hatteras Venture Partners, BioHealth Innovation (BHI) and Maryland Momentum Fund. Broad incumbents are New Enterprise Associates (NEA), Johnson & Johnson Innovation – JLABS, Roche Venture Fund and OrbiMed Advisors. TEDCO (Maryland Technology Development Corporation) is listed as a regional player.
Does Ecphora Capital have an API?
No public API is recorded for Ecphora Capital.
What industry is Ecphora Capital in?
Ecphora Capital's product category is Medtech Venture Capital. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 523940 and its SIC code is 6282.